Emerging Biosensors to Detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Review

Coronavirus disease (COVID-19) is a global health crisis caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) is the gold standard test for diagnosing COVID-19. Although it is highly accurate, this lab test req...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Wei Yin Lim, Boon Leong Lan, Narayanan Ramakrishnan
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/23bb5a65f0974384893eba17cec43582
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:23bb5a65f0974384893eba17cec43582
record_format dspace
spelling oai:doaj.org-article:23bb5a65f0974384893eba17cec435822021-11-25T16:55:20ZEmerging Biosensors to Detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Review10.3390/bios111104342079-6374https://doaj.org/article/23bb5a65f0974384893eba17cec435822021-11-01T00:00:00Zhttps://www.mdpi.com/2079-6374/11/11/434https://doaj.org/toc/2079-6374Coronavirus disease (COVID-19) is a global health crisis caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) is the gold standard test for diagnosing COVID-19. Although it is highly accurate, this lab test requires highly-trained personnel and the turn-around time is long. Rapid and inexpensive immuno-diagnostic tests (antigen or antibody test) are available, but these point of care (POC) tests are not as accurate as the RT-PCR test. Biosensors are promising alternatives to these rapid POC tests. Here we review three types of recently developed biosensors for SARS-CoV-2 detection: surface plasmon resonance (SPR)-based, electrochemical and field-effect transistor (FET)-based biosensors. We explain the sensing principles and discuss the advantages and limitations of these sensors. The accuracies of these sensors need to be improved before they could be translated into POC devices for commercial use. We suggest potential biorecognition elements with highly selective target-analyte binding that could be explored to increase the true negative detection rate. To increase the true positive detection rate, we suggest two-dimensional materials and nanomaterials that could be used to modify the sensor surface to increase the sensitivity of the sensor.Wei Yin LimBoon Leong LanNarayanan RamakrishnanMDPI AGarticlebiosensorCOVID-19 diagnosisSARS-CoV-2surface plasmon resonancefield-effect transistorelectrochemicalBiotechnologyTP248.13-248.65ENBiosensors, Vol 11, Iss 434, p 434 (2021)
institution DOAJ
collection DOAJ
language EN
topic biosensor
COVID-19 diagnosis
SARS-CoV-2
surface plasmon resonance
field-effect transistor
electrochemical
Biotechnology
TP248.13-248.65
spellingShingle biosensor
COVID-19 diagnosis
SARS-CoV-2
surface plasmon resonance
field-effect transistor
electrochemical
Biotechnology
TP248.13-248.65
Wei Yin Lim
Boon Leong Lan
Narayanan Ramakrishnan
Emerging Biosensors to Detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Review
description Coronavirus disease (COVID-19) is a global health crisis caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Real-time reverse transcriptase-polymerase chain reaction (RT-PCR) is the gold standard test for diagnosing COVID-19. Although it is highly accurate, this lab test requires highly-trained personnel and the turn-around time is long. Rapid and inexpensive immuno-diagnostic tests (antigen or antibody test) are available, but these point of care (POC) tests are not as accurate as the RT-PCR test. Biosensors are promising alternatives to these rapid POC tests. Here we review three types of recently developed biosensors for SARS-CoV-2 detection: surface plasmon resonance (SPR)-based, electrochemical and field-effect transistor (FET)-based biosensors. We explain the sensing principles and discuss the advantages and limitations of these sensors. The accuracies of these sensors need to be improved before they could be translated into POC devices for commercial use. We suggest potential biorecognition elements with highly selective target-analyte binding that could be explored to increase the true negative detection rate. To increase the true positive detection rate, we suggest two-dimensional materials and nanomaterials that could be used to modify the sensor surface to increase the sensitivity of the sensor.
format article
author Wei Yin Lim
Boon Leong Lan
Narayanan Ramakrishnan
author_facet Wei Yin Lim
Boon Leong Lan
Narayanan Ramakrishnan
author_sort Wei Yin Lim
title Emerging Biosensors to Detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Review
title_short Emerging Biosensors to Detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Review
title_full Emerging Biosensors to Detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Review
title_fullStr Emerging Biosensors to Detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Review
title_full_unstemmed Emerging Biosensors to Detect Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Review
title_sort emerging biosensors to detect severe acute respiratory syndrome coronavirus 2 (sars-cov-2): a review
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/23bb5a65f0974384893eba17cec43582
work_keys_str_mv AT weiyinlim emergingbiosensorstodetectsevereacuterespiratorysyndromecoronavirus2sarscov2areview
AT boonleonglan emergingbiosensorstodetectsevereacuterespiratorysyndromecoronavirus2sarscov2areview
AT narayananramakrishnan emergingbiosensorstodetectsevereacuterespiratorysyndromecoronavirus2sarscov2areview
_version_ 1718412824882970624